The past six months of crap in the spec market might see some traders a little frustrated, and looking in the wrong places for winners. Whatever it is, I'm against it!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025